Ellevest, Inc. Viatris Inc Transaction History

Ellevest, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$9.2 - $12.26 $2,023 - $2,697	220 Added 231.58%	315 $3,000
Q4 2022 Feb 03, 2023	SELL	$8.72 - $11.56 $7,603 - $10,080	-872 Reduced 90.18%	95 $1,000
Q3 2022 Nov 02, 2022	BUY	$8.48 - $11.13 $8,200 - $10,762	967 New	967 $8,000
Q1 2022 Apr 19, 2022	SELL	$9.81 - $15.4 $4,188 - $6,575	-427 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$12.09 - $14.68 $48 - $58	4 Added 0.95%	427 $6,000
Q3 2021 Oct 19, 2021	BUY	$13.25 - $15.13 $39 - $45	3 Added 0.71%	423 $6,000
Q2 2021 Jul 13, 2021	BUY	$12.97 - $16.15 $38 - $48	3 Added 0.72%	420 $6,000
Q1 2021 May 03, 2021	SELL	$13.59 - $18.54 $163 - $222	-12 Reduced 2.8%	417 $6,000
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $6,134 - $8,039	429 New	429 $8,000

1,095

965M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.